Enhancing the Use of GLP-1 RAs in Patients With Type 2 Diabetes to Improve Individualized Patient-Centered Care

Expert faculty provide insights on the use of GLP-1 receptor agonists for the treatment of type 2 diabetes. Learn about the glycemic and extraglycemic benefits of GLP-1 receptor agonists and how to tailor them to optimize the care of your patients.

Share

Provided by

ProCE Banner

Supporters

Novo Nordisk